EP 1838322 A2 20071003 - USE OF PURINE DERIVATIVES AS HSP90 PROTEIN INHIBITORS AND FOR TREATMENT OF CANCER
Title (en)
USE OF PURINE DERIVATIVES AS HSP90 PROTEIN INHIBITORS AND FOR TREATMENT OF CANCER
Title (de)
VERWENDUNG VON PURINDERIVATEN ALS HSP90-PROTEINHEMMER UND ZUR BEHANDLUNG VON KREBS
Title (fr)
UTILISATION DE DERIVES DE LA PURINE COMME INHIBITEURS DE LA PROTEINE HSP90 ET POUR LE TRAITEMENT DU CANCER
Publication
Application
Priority
- FR 2006000066 W 20060111
- FR 0500350 A 20050113
Abstract (en)
[origin: WO2006075095A2] The invention relates to the use of purine derivatives as Hsp90 protein chaperone inhibitors and more particularly the use thereof as inhibitors of the ATPase catalytic activity of the Hsp90 protein chaperone.
IPC 8 full level
A61K 31/52 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/52 (2013.01 - EP US); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2006075095A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
FR 2880540 A1 20060714; FR 2880540 B1 20080711; EP 1838322 A2 20071003; JP 2008526931 A 20080724; US 2008108612 A1 20080508; WO 2006075095 A2 20060720; WO 2006075095 A3 20061214
DOCDB simple family (application)
FR 0500350 A 20050113; EP 06709073 A 20060111; FR 2006000066 W 20060111; JP 2007550816 A 20060111; US 77357707 A 20070705